Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers-Reference-Cited by-同舟云学术

Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers

Published:2020-08-28 Issue:3 Volume:148 Page:702-712
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Okamura Ryosuke¹²^ORCID,Kurzrock Razelle¹²^ORCID,Mallory Robert J.³,Fanta Paul T.²,Burgoyne Adam M.²,Clary Bryan M.³,Kato Shumei¹²^ORCID,Sicklick Jason K.¹³^ORCID

Affiliation:

1. Center for Personalized Cancer Therapy UC San Diego Moores Cancer Center La Jolla California USA

2. Division of Hematology‐Oncology UC San Diego Moores Cancer Center La Jolla California USA

3. Division of Surgical Oncology, Department of Surgery UC San Diego Moores Cancer Center La Jolla California USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33230

Reference38 articles.

1. Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design

2. Molecular pathogenesis of biliary tract cancer

3. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

4. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

5. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy: paving a new avenue for cancer research;Cell Adhesion & Migration;2024-09

2. Circulating tumor DNA in management of primary liver malignancy: A review of the literature and future directions;Journal of Surgical Oncology;2024-08-19

3. The Search for Risk, Diagnostic, and Prognostic Biomarkers of Cholangiocarcinoma and Their Biological and Clinicopathologic Significance;The American Journal of Pathology;2024-08

4. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma;Scientific Reports;2024-07-13

5. Liquid biopsy into the clinics: Current evidence and future perspectives;The Journal of Liquid Biopsy;2024-06